This article needs additional citations for verification .(December 2007) |
Company type | Public (NYSE: TMO) |
---|---|
Founded | 17 March 1965 |
Headquarters | Waltham, Massachusetts, USA |
Key people | Marc N. Casper (President & CEO) |
Parent | Thermo Fisher Scientific |
Website | www.thermofisher.com |
Pierce Biotechnology Inc. is the ultimate origin of a number of products and product lines in the Thermo Fisher Scientific research and development division, "Thermo Scientific Pierce Protein Biology." The company from which this division originated, the Rockford, Illinois-based Pierce Chemical Company (PCC) was founded in 1948 when Alan Pierce assumed active management of a company known as Midwest Extraction, which focused on isolating chlorophyll from alfalfa (to take advantage of 1930s research arguing therapeutic uses for chlorophyll in infections, burns, and amputation).[ not verified in body ]
In assuming leadership of the company, Pierce transitioned the company to being a manufacturer of fine organic chemicals, giving it the PCC name in 1950. Among other advances, PCC was the first commercial manufacturer of ninhydrin for use in amino acid analysis. After the first several years, the company diversified into other products and markets.[ clarification needed ] Roy Oliver succeeded Pierce as company president in 1965 (Pierce remaining affiliated with eponymous products and business units until his retirement in 1994). Under Oliver, PCC expanded its operations internationally, entering into agreements with European distributors. The company's focus began to shift in the 1970s from the manufacture of organic chemical products at scale, to research, development, and production, of high-purity reagents for biotechnology research at smaller scales—resulting in its name chance to Pierce Biotechnology (PBT).[ when? ][ verification needed ] PBT became a subsidiary of Perstorp Group in the Perstorp Life Science Division, was spun off as a component of this division as Perbio Science AB, which was subsequently acquired by Fisher Scientific International in 2003.
Fisher merged with Thermo Electron in 2006, bringing some former PCC and PBT product lines of Perbio Science AB under Thermo Fisher Scientific management, as brands of its "Thermo Scientific Pierce Protein Biology" division.
In 1983, Perstorp, a Sweden-based chemical company, purchased Pierce. Perstorp was a manufacturer of chemicals, resins, plastics, and laminates.
In 1985, researchers at Pierce Chemical Company, led by Paul K. Smith, published a method detailing the use of bicinchoninic acid (BCA) as a protein quantitation reagent. [1] The BCA protein assay method maintains the high sensitivity and low variability among proteins associated with the Lowry protein assay, while providing increased tolerance to the presence of non-ionic detergents and buffer salts. The BCA assay has since become one of the most widely used methods of protein quantitation.
Pierce was recognized for its international marketing efforts in 1990 when it received the US President's "E" Award for success in exporting. Only 24 "E" awards were presented nationwide that year.
In 1995, Pierce Chemical Company introduced the patented SuperSignal chemiluminescent substrate for the chemiluminescent detection of biological molecules such as antibodies or pharmaceuticals. Chemiluminescence is the emission of light that occurs when a chemical reaction (in this case, between the SuperSignal Substrate and the tagged biological molecule) yields light. Researchers preserve the light signal on X-ray film or read the signal directly using an imager. Use of chemiluminescent technology allows researchers to replace radioactive tracers for greater personal safety and much less ecological impact.
The introduction of SuperSignal Substrate was one of many product introductions that propelled Pierce Chemical Company to become a leader in the areas of protein sample preparation, protein function and modification, and protein detection. The company would soon change its name to Pierce Biotechnology, Inc. to reflect its focus and expertise on these growing areas.
In June 1998, Pierce's parent company, Perstorp AB, announced several organizational changes, including the establishment of the separate Perstorp Life Science Division, of which Pierce was a key player. In 1999, the Perstorp Life Science Division was spun off into its own company, Perbio Science AB. The new company was listed on the Stockholm Stock Exchange O List in October 1999.
This section needs additional citations for verification .(March 2020) |
In August 2003, Fisher Scientific International announced its intent to purchase Perbio Science AB.[ citation needed ] In November 2006, Thermo Electron and Fisher Scientific International merged to form Thermo Fisher Scientific (TFS). [2] [ better source needed ] Today, the company formerly known as Pierce Chemical Company and Pierce Biotechnology Inc. is the TFS research and development division, "Thermo Scientific Pierce Protein Biology". [3]
Molecular biology is a branch of biology that seeks to understand the molecular basis of biological activity in and between cells, including biomolecular synthesis, modification, mechanisms, and interactions.
The enzyme-linked immunosorbent assay (ELISA) is a commonly used analytical biochemistry assay, first described by Eva Engvall and Peter Perlmann in 1971. The assay is a solid-phase type of enzyme immunoassay (EIA) to detect the presence of a ligand in a liquid sample using antibodies directed against the ligand to be measured. ELISA has been used as a diagnostic tool in medicine, plant pathology, and biotechnology, as well as a quality control check in various industries.
Chemiluminescence is the emission of light (luminescence) as the result of a chemical reaction, i.e. a chemical reaction results in a flash or glow of light. A standard example of chemiluminescence in the laboratory setting is the luminol test. Here, blood is indicated by luminescence upon contact with iron in hemoglobin. When chemiluminescence takes place in living organisms, the phenomenon is called bioluminescence. A light stick emits light by chemiluminescence.
The Bradford protein assay was developed by Marion M. Bradford in 1976. It is a quick and accurate spectroscopic analytical procedure used to measure the concentration of protein in a solution. The reaction is dependent on the amino acid composition of the measured proteins.
RiboGreen is a proprietary fluorescent dye that is used in the detection and quantification of nucleic acids, including both RNA and DNA. It is synthesized and marketed by Molecular Probes/Invitrogen of Eugene, Oregon, United States. In its free form, RiboGreen exhibits little fluorescence and possesses a negligible absorbance signature. When bound to nucleic acids, the dye fluoresces with an intensity that, according to the manufacturer, is several orders of magnitude greater than the unbound form. The fluorescence can be detected by a sensor and the nucleic acid can be quantified. The presence of protein contaminants in the sample of nucleic acids to be tested does not make significant contributions to the absorbance, and thus allows for the addition of deoxyribonucleases to the protocol in order to degrade DNA, in the instances where one is only interested in detecting or quantifying RNA.
Fisher Scientific International, Inc. was a laboratory supply and biotechnology company that provided products and services to the global scientific research and clinical laboratory markets until its merger with Thermo Electron in 2006, after which it became Thermo Fisher Scientific. The company offered products and services to over 350,000 customers located in approximately 150 countries including pharmaceutical and biotechnology companies, secondary and higher education institutions, hospitals and medical research institutions, and quality control, process control and research and development laboratories.
Invitrogen is one of several brands under the Thermo Fisher Scientific corporation. The product line includes various subbrands of biotechnology products, such as machines and consumables for polymerase chain reaction, reverse transcription, cloning, culturing, stem cell production, cell therapy, regenerative medicine, immunotherapy, transfection, DNA/RNA purification, diagnostic tests, antibodies, and immunoassays.
Sigma-Aldrich is an American chemical, life science, and biotechnology company owned by the multinational chemical conglomerate Merck Group.
The bicinchoninic acid assay, also known as the Smith assay, after its inventor, Paul K. Smith at the Pierce Chemical Company, now part of Thermo Fisher Scientific, is a biochemical assay for determining the total concentration of protein in a solution, similar to Lowry protein assay, Bradford protein assay or biuret reagent. The total protein concentration is exhibited by a color change of the sample solution from blue to purple in proportion to protein concentration, which can then be measured using colorimetric techniques. The BCA assay was patented by Pierce Chemical Company in 1989 & the patent expired in 2006.
In chemistry, the Biuret test, also known as Piotrowski's test, is a chemical test used for detecting the presence of at least two peptide bonds in a molecule. In the presence of peptides, a copper(II) ion forms mauve-colored coordination complexes in an alkaline solution. The reaction was first observed in 1833; In Poland, the biuret test is also known as Piotrowski's test in honor of the Polish physiologist Gustaw Piotrowski who independently rediscovered it in 1857. Several variants on the test have been developed, such as the BCA test and the Modified Lowry test.
The enzyme horseradish peroxidase (HRP), found in the roots of horseradish, is used extensively in biochemistry applications. It is a metalloenzyme with many isoforms, of which the most studied type is C. It catalyzes the oxidation of various organic substrates by hydrogen peroxide.
Thermo Fisher Scientific Inc. is an American-headquartered company and global supplier of analytical instruments, life sciences solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021).
The DyLight Fluor family of fluorescent dyes are produced by Dyomics in collaboration with Thermo Fisher Scientific. DyLight dyes are typically used in biotechnology and research applications as biomolecule, cell and tissue labels for fluorescence microscopy, cell biology or molecular biology.
FEI Company was an American company that designed, manufactured, and supported microscope technology. Headquartered in Hillsboro, Oregon, FEI had over 2,800 employees and sales and service operations in more than 50 countries around the world. Formerly listed on the NASDAQ, it is now a subsidiary of Thermo Fisher Scientific.
Fermentas was a biotechnology company specializing in the discovery and production of molecular biology products for life science research and diagnostics. Since 2010, Fermentas has been part of Thermo Fisher Scientific.
Dharmacon Inc., now known as Dharmacon, was founded in 1995 by Stephen Scaringe as Dharmacon Research to develop and commercialize a new technology for RNA oligonucleotide synthesis. Originally, the company's focus was to develop 2'-ACE RNA technology as the standard for RNA synthesis and to advance RNA oligo-dependent applications and technologies.
Bioreporters are intact, living microbial cells that have been genetically engineered to produce a measurable signal in response to a specific chemical or physical agent in their environment. Bioreporters contain two essential genetic elements, a promoter gene and a reporter gene. The promoter gene is turned on (transcribed) when the target agent is present in the cell’s environment. The promoter gene in a normal bacterial cell is linked to other genes that are then likewise transcribed and then translated into proteins that help the cell in either combating or adapting to the agent to which it has been exposed. In the case of a bioreporter, these genes, or portions thereof, have been removed and replaced with a reporter gene. As a result, turning on the promoter gene also turns on the reporter gene, leading to the production of reporter proteins that output a detectable signal. The presence of a signal indicates that the bioreporter has sensed a particular agent in its environment.
Virus quantification is counting or calculating the number of virus particles (virions) in a sample to determine the virus concentration. It is used in both research and development (R&D) in academic and commercial laboratories as well as in production situations where the quantity of virus at various steps is an important variable that must be monitored. For example, the production of virus-based vaccines, recombinant proteins using viral vectors, and viral antigens all require virus quantification to continually monitor and/or modify the process in order to optimize product quality and production yields and to respond to ever changing demands and applications. Other examples of specific instances where viruses need to be quantified include clone screening, multiplicity of infection (MOI) optimization, and adaptation of methods to cell culture.
James Henderson Naismith is Professor of Structural Biology at the University of Oxford, former Director of the Research Complex at Harwell and Director of the Rosalind Franklin Institute. He previously served as Bishop Wardlaw Professor of Chemical Biology at the University of St Andrews. He was a member of Council of the Royal Society (2021-2022). He is currently the Vice-Chair of Council of the European X-ray Free Electron Laser and Vice-President (non-clinical) of The Academy of Medical Sciences. It has been announced that he will be the Head of the MPLS division at Oxford in the autumn of 2023.
3-(4-Carboxybenzoyl)quinoline-2-carboxaldehyde (CBQCA) is a fluorogenic amine labeling dye that is not fluorescent itself, but covalently reacts with primary amines to form fluorescent products. It was first reported in 1991. Today, it is largely used in the context of quantifying peptides or proteins. Either cyanide or thiols are required as a co-substrate in the fluorogenic reaction, although thiols also react with & mask the CBQCA aldehyde thereby preventing the fluorogenic reaction against the targeted primary amines. Once bound to protein the excitation wavelength is 465 nm (blue) and the emission wavelength is ~550 nm (green).